A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913.
about
A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A randomized phase II study of ...... lts of NRG Oncology RTOG 0913.
@en
A randomized phase II study of ...... lts of NRG Oncology RTOG 0913.
@nl
type
label
A randomized phase II study of ...... lts of NRG Oncology RTOG 0913.
@en
A randomized phase II study of ...... lts of NRG Oncology RTOG 0913.
@nl
prefLabel
A randomized phase II study of ...... lts of NRG Oncology RTOG 0913.
@en
A randomized phase II study of ...... lts of NRG Oncology RTOG 0913.
@nl
P2093
P2860
P356
P1433
P1476
A randomized phase II study of ...... lts of NRG Oncology RTOG 0913.
@en
P2093
Amyn M Rojiani
Andrew Y Kee
Helen A Shih
Hsiang-Hsuan Michael Yu
John B Fiveash
Lynn S Ashby
Manmeet S Ahluwalia
Merideth M Wendland
Minesh P Mehta
Minhee Won
P2860
P356
10.1093/NEUONC/NOX209
P577
2017-11-06T00:00:00Z